Shaikh Zayed hospital Lahore
Lahore, Punjab Province, 54000, Pakistan
Location status: Recruiting
Location contact
Dr. Muhammad Imran Anwar, FCPS, FRCS
CONTACT
Dr. Rija Zainab, MS General surgery
CONTACT
NCT Number: NCT07517627
This randomized controlled trial aims to compare the mean operative time and outcomes of early versus delayed laparoscopic cholecystectomy after ERCP in patients with cholelithiasis and choledocholithiasis. Patients will be randomized into two groups: early cholecystectomy (within 72 hours of ERCP) and delayed cholecystectomy (≥1 month after ERCP). Outcomes include operative time, intra-operative blood loss, hospital stay, and conversion to open cholecystectomy
Interested in participating?
Request Info14 year–70 year
All sexes
Interventional
Not applicable
Lahore, Punjab Province, 54000, Pakistan
Location status: Recruiting
Dr. Muhammad Imran Anwar, FCPS, FRCS
CONTACT
Dr. Rija Zainab, MS General surgery
CONTACT
Gallstones are among the most common surgical problems worldwide, and up to 20% of patients with gallstones also present with stones in the common bile duct. Standard care involves clearance of bile duct stones, typically by Endoscopic Retrograde Cholangiopancreaticography (ERCP), followed by removal of the gallbladder by laparoscopic cholecystectomy (LC).
The timing of cholecystectomy after ERCP remains debated. Early LC (within 72 hours) has been associated with fewer recurrent biliary events, reduced hospital stay, and potentially easier operative conditions. However, delayed LC (after one month) continues to be widely practiced due to institutional factors and scheduling constraints.
This randomized controlled trial at Sheikh Zayed Hospital, Lahore, is designed to evaluate whether early LC after ERCP offers measurable advantages compared with delayed LC. Patients with confirmed cholelithiasis and choledocholithiasis will be randomized into two groups: early surgery and delayed surgery. The trial will provide local evidence to guide surgical practice, focusing on operative efficiency and patient recovery.
By clarifying the optimal timing of LC after ERCP in our patient population, the study aims to support evidence-based surgical decision-making, improve outcomes, and potentially reduce healthcare costs.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laparoscopic removal of gall bladder within 72hours of laparoscopic cholecystectomy
Laparoscopic removal of gall bladder 2 weeks or more after successful ERCP
Time frame: During surgery
Duration of surgery measured from the first incision to closure of the last incision.
Time frame: From admission to discharge (up to 30 days)
Total number of days from hospital admission to discharge.
Time frame: During Surgery
Blood loss measured in milliliters from suction apparatus during surgery.
Time frame: During Surgery
Number of patients requiring conversion from laparoscopic to open surgery
Contact information is provided by the study sponsor or research team.
Dr. Muhammad Imran Anwar, FCPS, FRCS
CONTACT
Dr. Rija Zainab, MS General surgery
CONTACT
Rija Zainab
Other
Comparative Analysis of Early Versus Delayed Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography (ERCP) in Patients of Cholelithiasis With Choledocholithiasis
Acronym: ED-LC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07413068
Cholelithiasis Associated With Common Bile Duct Stones
Jinan, Shandong, China
View Trial DetailsNCT07495111
Cholelithiasis Associated With Common Bile Duct Stones
Jinan, Shandong, China
View Trial Details